Vistagen Therapeutics, Inc. (VTGN) has 4 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 31, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 31, 2026 filed July 29, 2026 | Williamson Douglas J Director | $0 | 40,826 | 0% | No | |
|
|
||||||
| July 2, 2026 filed June 30, 2026 | Adler Reid G. Chief Legal Officer | $7,073 | 36,818 | +153% | No | |
|
|
||||||
| July 2, 2026 filed June 30, 2026 | Tressler Nick B. Chief Financial Officer | $2,250 | 11,712 | New | No | |
|
|
||||||
| July 2, 2026 filed June 30, 2026 | Singh Shawn President and CEO | $7,073 | 36,818 | +204% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free